trending Market Intelligence /marketintelligence/en/news-insights/trending/zpziz-4omrdpz6hq_s2ftg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Abbott to close acquisition of St. Jude Medical on Jan. 4, 2017

Mining Exploration Insights – May 2020

Essential Energy Insights - May 14, 2020

Paypal Well-Positioned To Gain Share In COVID-Related Digital Payments Shift

Credit Analytics Case Study: Provogue (India) Limited and Shree Renuka Sugars

Abbott to close acquisition of St. Jude Medical on Jan. 4, 2017

Abbott Laboratories plans to close its $25 billion acquisition of St. Jude Medical Inc. on Jan. 4, 2017.

The company has received all necessary regulatory approvals for the deal.

The acquisition is expected to be accretive to Abbott's adjusted EPS in the first full year and will increase after that, with about 21 cents of accretion in 2017 and an estimated 29 cents in 2018. It is also expected to result in annual pre-tax synergies of $500 million by 2020, including both sales and operational benefits.

The companies' combined cardiovascular and neuromodulation portfolio has annual sales of about $8.7 billion.